drugset / Trial / NCT04672720
L-carnitine and COH in PCOS Women Undergoing IVF/ICSI Cycles
RandomizedParallel-groupQuadruple-blindTreatment
Summary
The aim of this study was to evaluate the effect of oral L-carnitine supplementation during controlled ovarian stimulation (COS) in patients with polycystic ovary syndrome (PCOS) in a double-blind randomized clinical trial. The eligible patients with PCOS diagnosis (on the basis of Rotterdam criteria) who referred to Royan Research Institute for IVF / ICSI treatment cycles will be evaluated.
Timeline
- Start
- 2020-03-01
- Primary completion
- 2022-12-29
- Completion
- 2023-02-28
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | L-carnitine | Other / unclassified | 1000 mg | Oral |